Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up
Moderna Japan has received manufacturing and sales approval for its new COVID-19 vaccine, Emnex Spike®, for individuals aged 12 and above, enhancing immunization options.
third-news.com
May 20, 2026 at 3:02 AM
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan